Status:
UNKNOWN
Preliminary Establishment of the Medical Reference Range of Serum Vitamin K2 in Chinese Healthy Adults
Lead Sponsor:
Peking University Third Hospital
Conditions:
Health, Subjective
Eligibility:
All Genders
18-80 years
Brief Summary
Osteocalcin is a type of vitamin K2-dependent protein, and many studies have confirmed that vitamin K2 has anti-osteoporosis effects, and has preventive and therapeutic effects on a variety of disease...
Eligibility Criteria
Inclusion
- People aged over 18.
- People with normal routine blood test.
- Willing to participate in this study.
Exclusion
- Subjects with congenital metabolic problems and endocrine diseases.
- Treatment with any investigational drug within the past 3 months.
Key Trial Info
Start Date :
July 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2023
Estimated Enrollment :
465 Patients enrolled
Trial Details
Trial ID
NCT05436483
Start Date
July 31 2022
End Date
August 31 2023
Last Update
June 29 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.